Tridopa 150 Tablet

Presentation:Each tablet contains a combination of Levodopa BP 150 mg, Carbidopa BP 37.5 mg, and Entacapone BP 200 mg. 

Indications:Tridopa is indicated for the treatment of adult patients with Parkinson's disease experiencing end-of-dose motor fluctuations who are not stabilized on levodopa/dopa decarboxylase (DDC) inhibitor treatment.

Dosage and Administration: The optimal daily dose must be determined by careful titration of levodopa for each patient. Patients should be instructed to take only one tablet per dose administration. The maximum recommended daily dose of entacapone is 2,000 mg. This combination is usually for patients already treated with corresponding doses of standard-release levodopa or a DDC inhibitor and entacapone. Tridopa can be taken with or without food, but maintaining a consistent diet is advisable. Avoid high-protein meals as they may delay levodopa absorption. Swallow the tablet whole with water; do not break it. Dosage adjustments may be needed for patients on antihypertensive medication.

Side Effects:Common side effects include dyskinesia, nausea, hyperkinesia, change in urine color, diarrhea, and stomach pain.Otherpotential side effects include hallucinations, other mental disturbances, orthostatic hypotension, and symptoms resembling neuroleptic malignant syndrome.

Contraindications: Tridopa is contraindicated in patients with narrow-angle glaucoma, pheochromocytoma, a history of neuroleptic malignant syndrome (NMS) and/or non-traumatic rhabdomyolysis, severe hepatic impairment, and concurrent use of or within 14 days of discontinuing non-selective MAOIs. It is also contraindicated in patients with hypersensitivity to any of its components.

Precautions: Symptomatic postural hypotension may occur. Caution should be exercised when driving or using machinery as Tridopa may cause dizziness. Periodic monitoring of hepatic, renal, hematopoietic, and cardiovascular functions is recommended during prolonged therapy. Avoid abrupt withdrawal.

Drug Interactions: Tridopa may interact with dopamine receptor antagonists (e.g., some antipsychotics and antiemetics), phenytoin, papaverine, iron salts, and antihypertensive medications. Exercise caution with MAO inhibitors.

Pregnancy and Lactation: Tridopa should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus. Women should not breastfeed during treatment with this combination.

Storage:Store in a cool and dry place, protected from light. Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.